Kalra Sanjay
a Bharti Hospital, Bharti Research Institute of Diabetes and Endocrinology (BRIDE), Karnal, India.
Expert Rev Endocrinol Metab. 2014 Sep;9(5):423-425. doi: 10.1586/17446651.2014.931807. Epub 2014 Jun 25.
The α-glucosidase inhibitors are a time-tested, but under-utilized, class of oral hypoglycemic effects. Recent understanding of the importance of the incretin pathway, coupled with evidence about the incretin enhancing effects of these molecules, is covered in this editorial. The authors call for greater recognition of the beneficial effects of this class of drugs in the management of Type 2 diabetes.
α-葡萄糖苷酶抑制剂是一类经过长期考验但未得到充分利用的口服降糖药物。这篇社论涵盖了对肠促胰岛素途径重要性的最新认识，以及关于这些分子增强肠促胰岛素作用的证据。作者呼吁人们更加认识到这类药物在2型糖尿病管理中的有益作用。
